Balasubramanian et al., Recent Developments in Cancer Cytotoxics, Annual Reports in Medicinal Chemistry, vol. 33, pp. 151-159, 1998.* |
Draetta et al., Cell Cycle Control and Cancer, Annual Reports in Medicinal Chemistry, vol. 31, pp. 241-248, 1996.* |
Salmon et al., Principles of Cancer Therapy, Cecil Textbook of Medicine, 20th Edition, pp. 1036-1049, 1996.* |
Russell A. Barrow, et al., Total Synthesis of Cryptophycins. Revision of the Structures of Cryptophycins A and C. J. Am. Chem. Soc. (1995), 117, 2479-2490. |
Robert E. Schwartz, et al. Pharmaceuticals from Cultured Algae. Journal of Industrial Microbiology, 5 (1990) 113-123. |
Motomasa Kobayashi, et al. A total synthesis of Arenastatin A, an extremely potent cyctotoxic eepsipeptide, from the Okinawan marine sponge Dysidea Arenaria, Chem. Pharm. Bull. (1994) 42 (11) ; 2394-2396. |
Charles D. Smith, et al., Cryptophycin: A New Antimicrotubule Agent Active Against Drug-Resistant Cells. Cancer Research 54, 3779-3784, Jul. 15, 1994. |
Golakoti Trimurtulu, et al., Total Structures of Cryptophycins, Potent Antitumor Depsipeptides from the Blue-Green Alga Nostoc sp. Strain GSV 224. J. Am. Chem. Soc. 1994, 116, 4729-4737. |
Kristen Kerksiek, et al., Interaction of Cryptophycin 1 with Tubulin and Microtubules. FEBS Letters 377 (1995) 59-61. |
Motomasa Kobayashi, et al. Improved Total Synthesis and Structure-Activity Relationship of Arenastatin A, A Potent Cytotoxic Spongean Depsipeptide. Chem. Pharm. Bull 43 (9) 1598-1600 (1995). |
F. A. Valeriote, et al. Anticancer Activity of Cryptophycin Analogs. Proc. Amer. Assoc. Cancer Res., vol. 36, Mar. 1995, abstract 1802, 303. |
Trimurtulu Golakoti, et al. Structure Determination, Conformational Analysis, Chemical Stability Studies, and Antitumor Evaluation of the Cryptophycins. Isolation of 18 New Analogs from Nostoc sp. Strain GSV 224. J. Am. Chem. Soc., 1995, 117, 12030-12049. |
Ruoli Bai, et al. characterization of the interaction of cryptophycin 1 with tubulin: binding in the vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction. Cancer Research 56, 4398-4406, Oct. 1, 1996. |
Charles D. Smith, et al. Mechanism of Action of Cryptophycin. Journal of Biological Chemistry, vol. 271, No. 11, Mar. 15, 1996, pp. 6192-6198. |
Gregorz M. Salamonczyk, et al. Total Synthesis of Cryptophycins Via a Chemoenzymatic Approach J. Org. Chem., 1996, 61, 6893-6900. |
Rabindra Rej, et al. total synthesis of cryptophycins and their 16-(3-phenylacryloyl) derivatives. J. Org. Chem. 1996, 61, 6289-6295. |
Richard E. Moore, et al. The Search for New Antitumor Drugs from Blue-Green Algae. Current Pharmaceutical Design, 1996, 2, 317-330. |
T.H. Corbett, et al. Preclinical Anticancer Activity of Cryptophycin-8. Journal of Experimental Therapeutics and Oncology, vol. 1, No. 2, Mar. 1996, pp. 95-108. |
Dulal Panda, et al. Mechanism of Action of the Unusually Potent Microtubule Inhibitor Cryptophycin 1. Biochemistry 1997, 36, 12948-12953. |
L. Polin, et al. Preclinical Antitumor Activity of Cryptophycin-52/55 (C-52;C-55) Against Human Tumors in Scid Mice. Proc. Amer. Assoc. Cancer Res., vol. 38, Mar. 1997, abstract 1514, 225. |
Kevin M. Gardinier, et al. Enantiospecific Total Synthesis of the Potent Antitumor Macrolides Cryptophycins 1 and 8. J. Org. Chem. 1997, 62, 7098-7099. |
Syed M. Ali, et al., Formal Synthesis of Cryptophycin A and Arenastatin A. Tetrahedron Letters, vol. 38, No. 10, pp. 1703-1706, 1997. |
Gottumukkala V. Subbaraju, et al., Three New Cryptophycins from Nostoc sp. GSV 224, J. Nat. Prod., 1997, 60, 302-305. |